BioMarin Announces Fourth Quarter and Full Year 2021 Financial Results and Corporate Updates

Go back to BioMarin Announces Fourth Quarter and Full Year 2021 Financial Results and Corporate Updates
BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) Delayed: 55.95 +0.41 (0.74%)
Previous Close $55.54    52 Week High $108.96 
Open $55.54    52 Week Low $62.12 
Day High $56.26    P/E N/A 
Day Low $55.48    EPS $-1.27 
Volume 1,099,755